A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis-Reference-Cited by-同舟云学术

A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis

Published:1990-12 Issue:6 Volume:25 Page:774-780
ISSN:0435-1339
Container-title:Gastroenterologia Japonica
language:en
Short-container-title:Gastroenterol Jpn

Author:

Oka Hiroshi,Toda Gotaro,Ikeda Yusei,Hashimoto Naoaki,Hasumura Yasushi,Kamimura Tomoteru,Ohta Yasuyuki,Tsuji Takao,Hattori Nobu,Namihisa Toshihiko,Nishioka Mikio,Ito Ken’ichi,Sasaki Hiroshi,Kakumu Shin’ichi,Kuroki Tetsuo,Fujisawa Kiyoshi,Nakanuma Yasuo

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/BF02779195.pdf

Reference22 articles.

1. James SP, Hoofnagle JH, Strober W, et al: Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med 1983;99: 500–512

2. Matloff DS, Alpert E, Resnick RH, et al: A prospective trial of D-penicillamine in primay biliary cirrhosis. N Engl J Med 1982;306:319–326

3. Neuberger J, Christensen E, Portman B, et al: Double-blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. Gut 1985;26:114–119

4. Heathcote J, Ross A, Sherlock S, et al: A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976;76:656–660

5. Hoofnagle JH, Davis GL, Schafer DF, et al: Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986;91:1327–1334

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis;Gut Microbes;2023-05-16

2. Pharmacological Therapy of Pruritus in Primary Biliary Cholangitis;Journal of Clinical Gastroenterology;2022-11-18

3. Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-10-20

4. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease;Alimentary Pharmacology & Therapeutics;2019-11-25

5. Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis;Hepatology;2019-04-12